Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type I dependent manner.

Authors:
Kristina Durham
Kristina Durham
Thrombosis and Atherosclerosis Research Institute
Bernardo L Trigatti
Bernardo L Trigatti
McMaster University
Canada

Am J Physiol Heart Circ Physiol 2019 Apr 19. Epub 2019 Apr 19.

Biochemistry and Biomedical Sciences; and Thrombosis and Atherosclerosis Research Institute, McMaster University, Canada.

Doxorubicin, an agent used to treat a variety of cancers, is cardiotoxic by triggering cardiomyocyte apoptosis. We previously showed that treating cultured cardiomyocytes with human high density lipoprotein in vitro or transgenic overexpression of human apolipoprotein A1, its main structural protein protects against doxorubicin induced cardiomyocyte apoptosis in a manner dependent on the scavenger receptor class B type I [Durham (2018) 314: H31-H44]. This was due to high density lipoprotein induced activation of Akt signaling in cardiomyocytes. We now demonstrate that mice lacking the scavenger receptor class B type I exhibit increased sensitivity to doxorubicin-induced cardiomyocyte apoptosis in vivo. Cardiomyocytes expressing scavenger receptor class B type I are protected from doxorubicin-induced apoptosis by pre-incubation with high density lipoprotein isolated from wild type mice, whereas high density lipoprotein from scavenger receptor class B type 1 knockout mice is less effective. Cardiomyocytes from scavenger receptor class B type I knockout mice, however, are not protected by high density lipoprotein in vitro and hearts from knockout mice are more sensitive to doxorubicin in vivo. Pharmacological administration of purified apolipoprotein A1 dramatically protected wild type mice from doxorubicin-induced cardiotoxicity and left ventricular dysfunction, whereas this protection was lost in scavenger receptor class B type I-deficient mice. This demonstrates, at least in mice, that high density lipoprotein therapy can confer protection against doxorubicin-induced cardiomyocyte apoptosis in a manner mediated by the scavenger receptor class B type I.

Download full-text PDF

Source
https://www.physiology.org/doi/10.1152/ajpheart.00432.2018
Publisher Site
http://dx.doi.org/10.1152/ajpheart.00432.2018DOI Listing
April 2019
4 Reads

Publication Analysis

Top Keywords

class type
32
scavenger receptor
32
receptor class
32
density lipoprotein
24
high density
24
cardiomyocyte apoptosis
16
knockout mice
12
type
10
mice
9
mice high
8
lipoprotein vitro
8
apoptosis manner
8
doxorubicin-induced cardiomyocyte
8
type mice
8
wild type
8
type knockout
8
scavenger
8
receptor
8
mice doxorubicin-induced
8
class
8

Similar Publications